Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
4
×
Tags
biotech
boston blog main
cancer
4
×
deals
4
×
ipo
4
×
life sciences
national blog main
national top stories
san francisco blog main
venture capital
4
×
new york blog main
san diego blog main
san diego top stories
san francisco top stories
amgen
biogen
boston top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
crispr
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
new york top stories
novartis
raleigh-durham blog main
raleigh-durham top stories
revolution medicines
sanofi
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
vc
wisconsin blog main
wisconsin top stories
What
ipo
bio
medicines
plans
roundup
acquisitions
advance
announced
becker
billions
biology
cancer
ceo
collabs
company
covid
cytokine
daniel
deal
despite
dollars
drug
drugs
eaton
enhanced
family
files
gene
gilead
gilead’s
hardest
healthcare
help
hit
hottest
hunters
impact
initial
introduce
laying
Language
unset
Current search:
ipo
×
deals
×
cancer
×
photo
×
" venture capital "
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
@xconomy.com
4 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More
@xconomy.com
5 years ago
Synthorx Files for IPO to Advance Enhanced Cytokine Drugs